Latin America has been under-represented in dementia clinical trials, we must turn the corner…
The world’s population is aging, life expectancy is increasing in the past century as result of the improvements in healthcare and the people arrive to live longer and healthier. However, this has also resulted in increase the number of people with age-related diseases like most of dementia etiologi...
- Autores:
-
Allegri, Ricardo Francisco
Román, Fabian
Barcelo, Ernesto
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2022
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/9957
- Acceso en línea:
- https://hdl.handle.net/11323/9957
https://repositorio.cuc.edu.co/
- Palabra clave:
- Latin America
dementia clinical
clinical trials
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
| Summary: | The world’s population is aging, life expectancy is increasing in the past century as result of the improvements in healthcare and the people arrive to live longer and healthier. However, this has also resulted in increase the number of people with age-related diseases like most of dementia etiologies (fundamentally Alzheimer and Vascular dementia). The growth of people with dementia in the next 20 years will be exponential around the world but even more in those countries with Low and Medium Incomes (LMIC) due to the recently and future improve in health care and quality of life. |
|---|